# Clinical Deprescribing System - Features

## Core Features (Implemented in Prototype)

### 1. Patient Management
- ✅ Patient demographic entry (name, age, weight)
- ✅ Clinical information (renal function, conditions, fall history)
- ✅ Multi-condition selection from common diagnoses
- ✅ Auto-save functionality

### 2. Medication List Management
- ✅ Add/remove medications
- ✅ Medication details (name, dose, frequency, indication)
- ✅ Polypharmacy detection (5+ medications)
- ✅ Visual medication count tracking

### 3. Beers Criteria Analysis
- ✅ Automated screening against AGS Beers Criteria 2023
- ✅ 10 major drug classes covered:
  - Benzodiazepines
  - First-generation antihistamines
  - Proton pump inhibitors
  - NSAIDs
  - Anticholinergics
  - Antipsychotics
  - Sulfonylureas
  - Muscle relaxants
  - Tricyclic antidepressants
  - Digoxin

### 4. Risk Scoring System
- ✅ **Overall Risk Score** (0-10 scale)
- ✅ **Polypharmacy Risk** - Medication count assessment
- ✅ **Anticholinergic Burden** - Cumulative cognitive risk
- ✅ **Fall Risk** - Medication-related fall assessment
- ✅ Color-coded risk levels (low/medium/high)

### 5. Deprescribing Recommendations
- ✅ Evidence-based suggestions with citations
- ✅ Priority ranking (urgent/high/medium/low)
- ✅ Clinical rationale for each recommendation
- ✅ Alternative therapy suggestions
- ✅ Tapering protocols for medications requiring gradual withdrawal
- ✅ Monitoring plans with specific parameters

### 6. AI-Enhanced Insights
- ✅ GPT-4 powered clinical summaries
- ✅ Patient-specific considerations
- ✅ Actionable next steps for clinicians
- ✅ Natural language explanations

### 7. Clinician Workflow
- ✅ Step-by-step guided process
- ✅ Approve/reject recommendation workflow
- ✅ Documentation requirements
- ✅ No automated prescription changes
- ✅ Full clinician control

### 8. Safety Features
- ✅ Withdrawal syndrome warnings
- ✅ Tapering requirement alerts
- ✅ Evidence strength indicators
- ✅ Quality of evidence ratings
- ✅ Monitoring requirement specifications

## User Interface

### Design Principles
- Clean, professional healthcare interface
- Material-UI components for consistency
- Color-coded risk indicators
- Expandable recommendation cards
- Mobile-responsive design

### Key Screens
1. **Login** - Secure authentication
2. **Dashboard** - 3-step workflow (Patient → Medications → Analysis)
3. **Patient Form** - Comprehensive patient data entry
4. **Medication List** - Interactive medication management
5. **Analysis Results** - Detailed recommendations with evidence

## Technical Capabilities

### Backend
- RESTful API architecture
- In-memory data storage (prototype)
- Beers Criteria database
- Risk calculation algorithms
- OpenAI API integration

### Frontend
- React 18 with hooks
- Material-UI components
- Client-side state management
- Responsive design
- Real-time validation

## Future Enhancements (Not in Prototype)

### Phase 2 Features
- [ ] Database persistence (PostgreSQL)
- [ ] User authentication with JWT
- [ ] Multi-user support
- [ ] Patient history tracking
- [ ] PDF report generation
- [ ] EHR integration (HL7 FHIR)

### Phase 3 Features
- [ ] STOPP/START criteria
- [ ] Drug-drug interaction checking
- [ ] Drug-disease interaction checking
- [ ] Prescribing cascade detection
- [ ] Outcome tracking
- [ ] Analytics dashboard

### Phase 4 Features
- [ ] Machine learning predictions
- [ ] Natural language processing for clinical notes
- [ ] Mobile apps (iOS/Android)
- [ ] Telemedicine integration
- [ ] Multi-language support

## Clinical Guidelines Implemented

### AGS Beers Criteria 2023
- Potentially inappropriate medications
- Medications to avoid in older adults
- Medications to use with caution
- Drug-disease interactions
- Medications requiring dose adjustment

### Risk Assessment Tools
- Medication Burden Index
- Anticholinergic Cognitive Burden Scale
- Fall Risk Assessment
- Polypharmacy indicators

## Evidence Base

All recommendations include:
- Guideline citation (AGS Beers Criteria 2023)
- Recommendation strength (Strong/Moderate/Weak)
- Quality of evidence (High/Moderate/Low)
- Clinical rationale
- Supporting literature

## Compliance & Safety

### Built-in Safeguards
- No automated prescription changes
- Mandatory clinician review
- Documentation requirements
- Audit trail capability
- Evidence-based recommendations only

### Regulatory Considerations
- Designed for Clinical Decision Support exemption (FDA)
- HIPAA-ready architecture
- Audit logging capability
- User access controls

## Performance

- Fast analysis (<2 seconds without AI)
- AI insights in 3-5 seconds
- Responsive UI
- Scalable architecture
- Optimized for clinical workflow

## Browser Support

- Chrome (recommended)
- Firefox
- Safari
- Edge
- Mobile browsers (iOS Safari, Chrome Mobile)